Author:
Navarro A,Pairet S,Álvarez-Larrán A,Pons A,Ferrer G,Longarón R,Fernández-Rodríguez C,Camacho L,Monzó M,Besses C,Bellosillo B
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Campbell PJ, Green AR . The myeloproliferative disorders. N Engl J Med 2006; 355: 2452–2466.
2. Sanchez S, Ewton A . Essential thrombocythemia: a review of diagnostic and pathologic features. Arch Pathol Lab Med 2006; 130: 1144.
3. Kralovics R, Passamonti F, Buser AS, Teo S-S, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790.
4. Vainchenker W, Delhommeau F, Constantinescu SN, Bernard OA . New mutations and pathogenesis of myeloproliferative neoplasms. Blood 2011; 118: 1723–1735.
5. Kilpivaara O, Levine R . JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia 2008; 22: 1813–1817.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献